Full text is available at the source.
Abstract
Significant progress has been made in developing human, technical, and regulatory capacity for mRNA vaccine manufacturing in Africa.
- The development of human capacity is essential for supporting mRNA vaccine production on the continent.
- Technical advancements are key to establishing effective manufacturing processes for mRNA vaccines.
- Regulatory frameworks need to be enhanced to facilitate safe and efficient vaccine production.
- Several hurdles remain before a self-sustaining mRNA vaccine production ecosystem can be fully realized in Africa.
Simplified
mRNA Technology